TheraCryf (LSE:TCF) Accounts Payable: £1.82 Mil (As of Sep. 2025)


What is TheraCryf Accounts Payable?

TheraCryf LSE:TCF Accounts Payable is £1.82 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

TheraCryf's Accounts Payable for the quarter that ended in Sep. 2025 was £1.82 Mil.

TheraCryf's quarterly Accounts Payable declined from Sep. 2024 (£0.47 Mil) to Mar. 2025 (£0.11 Mil) but then increased from Mar. 2025 (£0.11 Mil) to Sep. 2025 (£1.82 Mil).

TheraCryf's annual Accounts Payable declined from Mar. 2023 (£0.40 Mil) to Mar. 2024 (£0.33 Mil) and declined from Mar. 2024 (£0.33 Mil) to Mar. 2025 (£0.11 Mil).

TheraCryf Accounts Payable Historical Data

* Premium members only.

The historical data trend for TheraCryf's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Accounts Payable Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.07 0.40 0.33 0.11

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.33 0.47 0.11 1.82

TheraCryf Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of £1.82 Mil mean?
TheraCryf (LSE:TCF) has a Accounts Payable of £1.82 Mil as of Sep. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on TheraCryf and its competitors.
Is TheraCryf's Accounts Payable too high?
TheraCryf's current Accounts Payable is £1.82 Mil.
How does TheraCryf's Accounts Payable compare to VRTX and REGN?
TheraCryf's Accounts Payable of £1.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on TheraCryf and its competitors. TheraCryf's current Accounts Payable is £1.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current Accounts Payable of £1.82 Mil. The current Accounts Payable is £1.82 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Accounts Payable is £1.82 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.